The Machines Are Hiring (And Firing)

Reuters reports that after AI features were added to Acclarent’s TruDi sinus-navigation system, FDA malfunction and adverse-event reports tied to the device rose from single digits pre-AI to at least 100 reports, including at least 10 reported injuries between late 2024 and November 2025. Reuters also describes alleged navigation failures in surgeries, including a reported skull-base puncture case, while noting litigation disputes over causation. The FDA’s own public list shows 1,300+ AI-enabled medical devices authorized for U.S. marketing, underscoring how fast deployment is scaling across specialties. The contradiction is now obvious: hospitals are getting AI at platform speed while post-market safety fights still run at analog pace.

AP reports U.S. Defense Secretary Pete Hegseth pressured Anthropic to broaden military access to its models, while Anthropic kept red lines around domestic mass surveillance and fully autonomous targeting. In a follow-up, the administration then ordered agencies to stop using Anthropic in classified workflows, and Anthropic said it would challenge the move. OpenAI announced an agreement with the Pentagon shortly after, with CEO Sam Altman saying the deal includes prohibitions on domestic mass surveillance and autonomous use-of-force without human responsibility. The signal to the whole industry: ‘safety policy’ is no longer a blog topic — it’s now a contract clause with teeth.

Block announced it’s cutting roughly 4,000 roles — about 10% of its workforce — as CEO Jack Dorsey pushes to replace human workers with AI agents across operations. The stock climbed on the news. Internal memos reportedly frame the layoffs as a structural shift rather than a cost-cutting round, positioning AI agents as permanent replacements for entire functions rather than tools that augment existing teams. The market’s response is the quiet part said loud: investors reward headcount reduction dressed up as innovation. The employees don’t get a stock bump.